Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shanghai - Delayed Quote CNY

Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS)

Compare
20.45
-0.25
(-1.21%)
At close: 3:00:04 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Hongqi Wang Vice Chairman & GM -- -- 1964
Mr. Xu Li Deputy GM & Director -- -- 1986
Mr. Hai Bin Li Deputy GM & Director -- -- 1972
Mr. Xin Zhe Yang Deputy GM & Secretary -- -- 1974
Mr. Yu Zhang Deputy GM and R&D Director -- -- 1986
Yi Qing Chen Deputy GM & CFO -- -- --
Dr. Huang Jiaxue Chief Technical Quality Officer -- -- --
Mr. Yueming Wang Chief Human Resources Officer -- -- --

Vcanbio Cell & Gene Engineering Corp., Ltd

Huayuan Industrial Zone
No. 12 Meiyuan Road Binhai High-tech Zone
Tianjin, 300384
China
86 22 5877 5766 https://www.vcanbio.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
2,209

Description

Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, primarily engages in the preparation and storage of cell detection tests in the People's Republic of China. The company provides cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental sub totipotent stem cells, immune cells, adipose stem cells, and dental stem cells. It also provides genetic testing services related to non-invasive prenatal genetic testing during pregnancy, genetic testing for drug safety guidance, disease genetic testing, and disease susceptibility testing for children and adults; and in vitro diagnostic raw materials, such as monoclonal antibodies and polyclonal antibody products. In addition, the company is involved in the research, development, production, and sales of biological genes, proteins, antibodies, pharmaceutical intermediates, and synthetic agents; and in vitro diagnostic reagents and medical devices. The company was founded in 1992 and is based in Tianjin, the People's Republic of China.

Corporate Governance

Vcanbio Cell & Gene Engineering Corp., Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

August 10, 2001 at 12:00 AM UTC

Ex-Dividend Date